ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 764

Cardiovascular Disease in SLE at One Center between 1981 and 2016. a Population-Based Study Highlighting the Importance of Disease Duration and Age at Diagnosis

Ola Nived1, Ragnar F Ingvarsson1, Anna Jöud2, Petrus Linge1, Helena Tydén1, Anders A. Bengtsson1 and Andreas Jönsen1, 1Rheumatology, Lund University, Department of Clinical Sciences, Lund, Sweden, 2Division of Occupational and Environmental Medicine, Lund University, Department of Laboratory Medicine, Lund, Sweden

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: SLE and cardiovascular disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Active inflammatory processes characterize early SLE disease, while later morbidity to a considerable extent consists of consequences of organ damage, particularly cardiovascular disease (CVD). In this study, we report on the frequency of acute myocardial infarctions and stroke in incident SLE cases in a defined population over an extended time.

Methods: The current study includes SLE patients followed at the Department of Rheumatology in Lund, Sweden, diagnosed 1981 through 2006. First, we compare incidence rates of acute myocardial infarctions (AMI) and cerebrovascular incidents (CVI) between all incident SLE cases within 8 counties, through the years 1998-2016, and the population. This time constraint is due to the availability of reliable electronic health care information for the population only from 1998 and forward. Second, we describe AMI and stroke incidence patterns in SLE patients 1981-2016 in an extended cohort. Only the first events of AMI and CVI respectively, both among SLE patients and in the population, were used for calculations.

Results: In all, 276 SLE patients were included in the study. From the defined 8 counties 175 SLE patients were studied and thus 101 patients from outside this region were included. Overall, 38 AMI and 44 CVI were recorded in 72 SLE patients, thus 10 patients had suffered both from an AMI and a CVI. The incidence rate-ratio for AMI was 3.0 in SLE overall (CI 1.3-6.9 (99.9%) p<0.001) compared with the population. Significantly increased rate-ratios of AMI were seen in women <40 and between 40-59 years of age, while for males only the age group 40-59 years had an increased incidence of AMI. SLE patients with a higher age at diagnosis (>54 years) had a shorter disease duration before suffering an AMI compared to SLE patients diagnosed at a younger age (median 7 years vs 18 years, p<0.05). The incidence rate-ratio for CVI in SLE overall was 3.2 (CI 1.6-6.6 (99.9%) p<0.001) compared to the population. An increased CVI incidence was only significant for women in the age group 40-59 years. Males were few and had only 2 events in the higher age group.

Conclusion: SLE patients are at risk of developing early myocardial infarctions and cerebrovascular incidents compared with the population. Patients with a younger age at SLE diagnosis may develop AMI after a longer disease duration compared to older patients.


Disclosure: O. Nived, None; R. F. Ingvarsson, None; A. Jöud, None; P. Linge, None; H. Tydén, None; A. A. Bengtsson, None; A. Jönsen, None.

To cite this abstract in AMA style:

Nived O, Ingvarsson RF, Jöud A, Linge P, Tydén H, Bengtsson AA, Jönsen A. Cardiovascular Disease in SLE at One Center between 1981 and 2016. a Population-Based Study Highlighting the Importance of Disease Duration and Age at Diagnosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/cardiovascular-disease-in-sle-at-one-center-between-1981-and-2016-a-population-based-study-highlighting-the-importance-of-disease-duration-and-age-at-diagnosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiovascular-disease-in-sle-at-one-center-between-1981-and-2016-a-population-based-study-highlighting-the-importance-of-disease-duration-and-age-at-diagnosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology